Commercialization Leadership Team
- Adam Kuspa, Ph.D., Senior Vice President of Research, Chief Ventures Officer
As leader of the college’s research activities and enterprise, Dr. Kuspa is charged with overseeing and coordinating all innovation development and commercialization activities at Baylor College of Medicine. Dr. Kuspa’s leadership has been instrumental in the development of the integrated multifunctional team approach to commercialization at Baylor.
Responsibilities: development and execution of strategic vision for research and commercialization, allocation of institutional resources, maintaining extensive research infrastructure, advancing research at affiliated institutions, integrating clinical and translational research across the College, and promoting the commercial development of discoveries that result.
- Shawn Davis, Vice President of Research, Deputy Chief Ventures Officer
Responsibilities: advancing strategic vision for research and commercialization, overseeing operational and business aspects of research and commercial activities, leads research mission planning, development and improvement, manages allocation of institutional resources in support of research and commercial infrastructure, executes research vision in collaboration with affiliate relationships, oversees Baylor’s strategic relationships with external commercial partners, ensures an integrated approach to commercialization aligned to institutional vision.
- Michael Dilling, Ph.D., Executive Director, Baylor Licensing Group
Dr. Dilling directs the activities of the team that is responsible for managing and licensing Baylor’s intellectual property assets. Director of the Baylor Licensing Group since 2011, Dr. Dilling has 14 years of technology licensing experience at Baylor. Dr. Dilling has a Ph.D. in Genetics from Texas A&M University and an MBA from the University of Memphis.
- Caroline Popper, M.D., President, BCM Technologies
Dr. Popper directs the activities of BCM Technologies, Baylor’s wholly-owned for-profit venture development subsidiary. BCMT is responsible for managing and administering start-up company formation for new ventures formed around the college’s biomedical assets. President of BCM Technologies since 2007, Dr. Popper also leads the activities of Popper & Company, a biomedical industry consulting firm. Dr. Popper has more than 21 years of hands-on biotech/life sciences operating experience. An internist and pathologist, she combines medical and scientific perspective with knowledge gained from managing a wide spectrum of life sciences businesses in diagnostics, devices and drug discovery. Dr. Popper has an M.D. from the University of Witwatersrand (South Africa) and her M.P.H. from Johns Hopkins University.